Camelia Bucsa

6PUBLICATIONS
6CO-AUTHORS
PharmacogenomicsInfant and child healthDisease surveillanceToxicology (incl. clinical toxicology)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 27, 2025
Adverse Drug Reactions to SGLT2i Reported by Type 2 Diabetes New Users: An Active Surveillance Study.

Camelia Bucșa, Ioana Frenț, Ramona Stefan

|Jun 24, 2022
Safety of Antibiotics in Hospitalized Children in Romania: A Prospective Observational Study.

Noémi-Beátrix Bulik, Andreea Farcaș, Camelia Bucșa

|Jun 22, 2021
An investigation on the association between sodium glucose co-transporter 2 inhibitors use and acute pancreatitis: A VigiBase study.

Ioana Frent, Camelia Bucsa, Daniel Leucuta

|Jun 02, 2021
Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly.

Mariana Sipos, Andreea Farcas, Daniel Corneliu Leucuta

|Mar 19, 2020
A description of medicines-related safety issues evaluated through a referral procedure at the EU level after 2012.

Andreea Farcas, Teodora Balcescu, Laura Anghel

|Nov 12, 2018
Applying DoTS adverse drug reactions classification to reports from hospital stimulated reporting.

Andreea Farcas, Noemi Beatrix Bulik, Andreea Popa

Pageof 1